Identification
4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,1,3-benzothiadiazole
Molecular Formula:
C18H26B2N2O4S
Suppliers
CAS equal suppliers
2,1,3-Benzothiadiazole-4,7-bis(boronic acid pinacol ester)
Santa Cruz Biotechnology, Inc.
288325
2,1,3-Benzothiadiazole-4,7-bis(boronic acid pinacol ester)
Chemieliva Pharmaceutical Co., Ltd.
CP1218036540
2,1,3-Benzothiadiazole-4,7-bis(boronic acid pinacol ester)
Leap Chem Co., Ltd
LC626418792
2,1,3-Benzothiadiazole-4,7-bis(boronic acid pinacol ester)
Finipharma Ltd
F48729744
2,1,3-Benzothiadiazole-4,7-bis(boronic acid pinacol ester)
Ascender Chemical Co.,Ltd
ACC870034800
4,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole
Pharmacore Co., Limited
PL1255837674
4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole
Ambeed, Inc.
A140865
4,7-bis-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole
BLD Pharmatech Ltd
BP995429862
Prices & Availability
Data is processed
x
Properties for 4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,1,3-benzothiadiazole
Molecular Weight:
388.10 g·mol−1
Melting point:
207-212 °C
x
Hazard Statements
GHS03
Harmful
- Acute toxicity (oral, dermal, inhalation), category 4
- Skin irritation, categories 2, 3
- Eye irritation, category 2A
- Skin sensitization, category 1
- Specific target organ toxicity following single exposure, category 3
- Respiratory tract irritation
- Narcotic effects
Not used
- with the "skull and crossbones" pictogram
- for skin or eye irritation if:
- the "corrosion" pictogram also appears
- the "health hazard" pictogram is used to indicate respiratory sensitization
Safety & Transport Information
x
Alternative Distributors of [4,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,1,3-benzothiadiazole]
Producers or manufacturers change the product range from time to time.
Currently there are no other manufacturers known.